Skip to main content
Erschienen in: Cancer Causes & Control 9/2017

04.07.2017 | Original Paper

Circulating leptin and adiponectin, and breast density in premenopausal Mexican women: the Mexican Teachers’ Cohort

verfasst von: L. Dossus, S. Rinaldi, C. Biessy, M. Hernandez, M. Lajous, A. Monge, E. Ortiz-Panozo, E. Yunes, R. Lopez-Ridaura, G. Torres-Mejía, I. Romieu

Erschienen in: Cancer Causes & Control | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Leptin and adiponectin are produced by the adipose tissue. Mammographic density (MD) is one of the strongest predictors of breast cancer (BC) and is highly influenced by adiposity. How the interplay between MD, obesity, and obesity-related biomarkers influences BC risk, however, is still unknown, especially in premenopausal women, where adiposity seems to be protective for BC. The aim of the present study was to explore the association between circulating leptin, adiponectin, and their ratio, with MD in Mexican premenopausal women who are part of the large Mexican Teachers’ Cohort (MTC).

Methods

A subsample of 2,084 women from the MTC participated in a clinical evaluation. Of them, 574 premenopausal women were randomly selected, from four MD strata. Serum leptin and adiponectin concentrations were measured by immunoassays. Multivariate regression analyses were performed to compare means of MD by quartiles of adipokines and their ratio.

Results

High leptin and leptin/adiponectin ratio levels were significantly associated with lower percentage MD and higher absolute and non-absolute dense tissue areas. High adiponectin levels were significantly associated with lower absolute dense and non-dense tissue areas, but not with percentage MD. After adjustment for BMI, only the associations between percentage MD and absolute non-dense tissue area with leptin remained statistically significant.

Conclusions

Leptin, adiponectin, and their ratio were associated with MD; however, only the positive association with leptin seemed to be independent from overall obesity.
Literatur
1.
Zurück zum Zitat Yadav A, Kataria MA, Saini V, Yadav A (2013) Role of leptin and adiponectin in insulin resistance. Clin Chim Acta 417:80–84CrossRefPubMed Yadav A, Kataria MA, Saini V, Yadav A (2013) Role of leptin and adiponectin in insulin resistance. Clin Chim Acta 417:80–84CrossRefPubMed
2.
Zurück zum Zitat Hocking S, Samocha-Bonet D, Milner KL, Greenfield JR, Chisholm DJ (2013) Adiposity and insulin resistance in humans: the role of the different tissue and cellular lipid depots. Endocr Rev 34(4):463–500CrossRefPubMed Hocking S, Samocha-Bonet D, Milner KL, Greenfield JR, Chisholm DJ (2013) Adiposity and insulin resistance in humans: the role of the different tissue and cellular lipid depots. Endocr Rev 34(4):463–500CrossRefPubMed
3.
Zurück zum Zitat Hu X, Juneja SC, Maihle NJ, Cleary MP (2002) Leptin—a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 94(22):1704–1711CrossRefPubMed Hu X, Juneja SC, Maihle NJ, Cleary MP (2002) Leptin—a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 94(22):1704–1711CrossRefPubMed
4.
Zurück zum Zitat Tilg H, Wolf AM (2005) Adiponectin: a key fat-derived molecule regulating inflammation. Expert Opin Ther Targets. 9(2):245–251CrossRefPubMed Tilg H, Wolf AM (2005) Adiponectin: a key fat-derived molecule regulating inflammation. Expert Opin Ther Targets. 9(2):245–251CrossRefPubMed
5.
Zurück zum Zitat Mohammadzadeh G, Ghaffari MA, Bafandeh A, Hosseini SM (2014) Association of serum soluble leptin receptor and leptin levels with breast cancer. J Res Med Sci. 19(5):433–438PubMedPubMedCentral Mohammadzadeh G, Ghaffari MA, Bafandeh A, Hosseini SM (2014) Association of serum soluble leptin receptor and leptin levels with breast cancer. J Res Med Sci. 19(5):433–438PubMedPubMedCentral
6.
Zurück zum Zitat Ye J, Jia J, Dong S, Zhang C, Yu S, Li L et al (2014) Circulating adiponectin levels and the risk of breast cancer: a meta-analysis. Eur J Cancer Prev 23(3):158–165CrossRefPubMed Ye J, Jia J, Dong S, Zhang C, Yu S, Li L et al (2014) Circulating adiponectin levels and the risk of breast cancer: a meta-analysis. Eur J Cancer Prev 23(3):158–165CrossRefPubMed
7.
Zurück zum Zitat Niu J, Jiang L, Guo W, Shao L, Liu Y, Wang L (2013) The association between leptin level and breast cancer: a meta-analysis. PLoS ONE 8(6):e67349CrossRefPubMedPubMedCentral Niu J, Jiang L, Guo W, Shao L, Liu Y, Wang L (2013) The association between leptin level and breast cancer: a meta-analysis. PLoS ONE 8(6):e67349CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Macis D, Guerrieri-Gonzaga A, Gandini S (2014) Circulating adiponectin and breast cancer risk: a systematic review and meta-analysis. Int J Epidemiol 43(4):1226–1236CrossRefPubMedPubMedCentral Macis D, Guerrieri-Gonzaga A, Gandini S (2014) Circulating adiponectin and breast cancer risk: a systematic review and meta-analysis. Int J Epidemiol 43(4):1226–1236CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Rinaldi S, Biessy C, de la Luz Hernandez M, Lajous M, Ortiz-Panozo E, Yunes E et al (2015) Endogenous hormones, inflammation, and body size in premenopausal Mexican women: results from the Mexican Teachers’ Cohort (MTC, ESMaestras). Cancer Causes Control 26(3):475–486CrossRefPubMed Rinaldi S, Biessy C, de la Luz Hernandez M, Lajous M, Ortiz-Panozo E, Yunes E et al (2015) Endogenous hormones, inflammation, and body size in premenopausal Mexican women: results from the Mexican Teachers’ Cohort (MTC, ESMaestras). Cancer Causes Control 26(3):475–486CrossRefPubMed
10.
Zurück zum Zitat Harris HR, Tworoger SS, Hankinson SE, Rosner BA, Michels KB (2011) Plasma leptin levels and risk of breast cancer in premenopausal women. Cancer Prev Res (Phila). 4(9):1449–1456CrossRefPubMedPubMedCentral Harris HR, Tworoger SS, Hankinson SE, Rosner BA, Michels KB (2011) Plasma leptin levels and risk of breast cancer in premenopausal women. Cancer Prev Res (Phila). 4(9):1449–1456CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Tworoger SS, Eliassen AH, Kelesidis T, Colditz GA, Willett WC, Mantzoros CS et al (2007) Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab 92(4):1510–1516CrossRefPubMed Tworoger SS, Eliassen AH, Kelesidis T, Colditz GA, Willett WC, Mantzoros CS et al (2007) Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab 92(4):1510–1516CrossRefPubMed
12.
Zurück zum Zitat McCormack VA, dos Santos Silva I (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15(6):1159–1169CrossRefPubMed McCormack VA, dos Santos Silva I (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15(6):1159–1169CrossRefPubMed
13.
Zurück zum Zitat Furberg AS, Jasienska G, Bjurstam N, Torjesen PA, Emaus A, Lipson SF et al (2005) Metabolic and hormonal profiles: HDL cholesterol as a plausible biomarker of breast cancer risk. The Norwegian EBBA Study. Cancer Epidemiol Biomarkers Prev 14(1):33–40PubMed Furberg AS, Jasienska G, Bjurstam N, Torjesen PA, Emaus A, Lipson SF et al (2005) Metabolic and hormonal profiles: HDL cholesterol as a plausible biomarker of breast cancer risk. The Norwegian EBBA Study. Cancer Epidemiol Biomarkers Prev 14(1):33–40PubMed
14.
Zurück zum Zitat Maskarinec G, Woolcott C, Steude JS, Franke AA, Cooney RV (2010) The relation of leptin and adiponectin with breast density among premenopausal women. Eur J Cancer Prev 19(1):55–60CrossRefPubMedPubMedCentral Maskarinec G, Woolcott C, Steude JS, Franke AA, Cooney RV (2010) The relation of leptin and adiponectin with breast density among premenopausal women. Eur J Cancer Prev 19(1):55–60CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Morimoto Y, Conroy SM, Ollberding NJ, Kim Y, Lim U, Cooney RV et al (2014) Ethnic differences in serum adipokine and C-reactive protein levels: the multiethnic cohort. Int J Obes (Lond). 38(11):1416–1422CrossRefPubMedCentral Morimoto Y, Conroy SM, Ollberding NJ, Kim Y, Lim U, Cooney RV et al (2014) Ethnic differences in serum adipokine and C-reactive protein levels: the multiethnic cohort. Int J Obes (Lond). 38(11):1416–1422CrossRefPubMedCentral
16.
Zurück zum Zitat Cho YA, Sung MK, Yeon JY, Ro J, Kim J (2013) Prognostic role of interleukin-6, interleukin-8, and leptin levels according to breast cancer subtype. Cancer Res Treat. 45(3):210–219CrossRefPubMedPubMedCentral Cho YA, Sung MK, Yeon JY, Ro J, Kim J (2013) Prognostic role of interleukin-6, interleukin-8, and leptin levels according to breast cancer subtype. Cancer Res Treat. 45(3):210–219CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Romieu I, Escamilla-Nunez MC, Sanchez-Zamorano LM, Lopez-Ridaura R, Torres-Mejia G, Yunes EM et al (2012) The association between body shape silhouette and dietary pattern among Mexican women. Public Health Nutr. 15(1):116–125CrossRefPubMed Romieu I, Escamilla-Nunez MC, Sanchez-Zamorano LM, Lopez-Ridaura R, Torres-Mejia G, Yunes EM et al (2012) The association between body shape silhouette and dietary pattern among Mexican women. Public Health Nutr. 15(1):116–125CrossRefPubMed
18.
Zurück zum Zitat Lajous M, Ortiz-Panozo E, Monge A, Santoyo-Vistrain R, Garcia-Anaya A, Yunes-Diaz E et al (2015) Cohort profile: the Mexican Teachers’ Cohort (MTC). Int J Epidemiol. doi:10.1093/ije/dyv123 Lajous M, Ortiz-Panozo E, Monge A, Santoyo-Vistrain R, Garcia-Anaya A, Yunes-Diaz E et al (2015) Cohort profile: the Mexican Teachers’ Cohort (MTC). Int J Epidemiol. doi:10.​1093/​ije/​dyv123
19.
Zurück zum Zitat Rice MS, Biessy C, Lajous M, Bertrand KA, Tamimi RM, Torres-Mejia G et al (2013) Metabolic syndrome and mammographic density in Mexican women. Cancer Prev Res (Phila). 6(7):701–710CrossRefPubMedPubMedCentral Rice MS, Biessy C, Lajous M, Bertrand KA, Tamimi RM, Torres-Mejia G et al (2013) Metabolic syndrome and mammographic density in Mexican women. Cancer Prev Res (Phila). 6(7):701–710CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Angeles-Llerenas A, Ortega-Olvera C, Perez-Rodriguez E, Esparza-Cano JP, Lazcano-Ponce E, Romieu I et al (2010) Moderate physical activity and breast cancer risk: the effect of menopausal status. Cancer Causes Control 21(4):577–586CrossRefPubMed Angeles-Llerenas A, Ortega-Olvera C, Perez-Rodriguez E, Esparza-Cano JP, Lazcano-Ponce E, Romieu I et al (2010) Moderate physical activity and breast cancer risk: the effect of menopausal status. Cancer Causes Control 21(4):577–586CrossRefPubMed
21.
Zurück zum Zitat Rinaldi S, Biessy C, Hernandez M, Lesueur F, dos-Santos-Silva I, Rice MS et al (2014) Circulating concentrations of insulin-like growth factor-I, insulin-like growth factor-binding protein-3, genetic polymorphisms and mammographic density in premenopausal Mexican women: results from the ESMaestras cohort. Int J Cancer 134(6):1436–1444CrossRefPubMed Rinaldi S, Biessy C, Hernandez M, Lesueur F, dos-Santos-Silva I, Rice MS et al (2014) Circulating concentrations of insulin-like growth factor-I, insulin-like growth factor-binding protein-3, genetic polymorphisms and mammographic density in premenopausal Mexican women: results from the ESMaestras cohort. Int J Cancer 134(6):1436–1444CrossRefPubMed
22.
Zurück zum Zitat Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E et al (2007) Mammographic density and the risk and detection of breast cancer. N Engl J Med 356(3):227–236CrossRefPubMed Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E et al (2007) Mammographic density and the risk and detection of breast cancer. N Engl J Med 356(3):227–236CrossRefPubMed
23.
Zurück zum Zitat Macis D, Gandini S, Guerrieri-Gonzaga A, Johansson H, Magni P, Ruscica M et al (2012) Prognostic effect of circulating adiponectin in a randomized 2 × 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer. J Clin Oncol 30(2):151–157CrossRefPubMed Macis D, Gandini S, Guerrieri-Gonzaga A, Johansson H, Magni P, Ruscica M et al (2012) Prognostic effect of circulating adiponectin in a randomized 2 × 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer. J Clin Oncol 30(2):151–157CrossRefPubMed
25.
Zurück zum Zitat Petridou E, Papadiamantis Y, Markopoulos C, Spanos E, Dessypris N, Trichopoulos D (2000) Leptin and insulin growth factor I in relation to breast cancer (Greece). Cancer Causes Control 11(5):383–388CrossRefPubMed Petridou E, Papadiamantis Y, Markopoulos C, Spanos E, Dessypris N, Trichopoulos D (2000) Leptin and insulin growth factor I in relation to breast cancer (Greece). Cancer Causes Control 11(5):383–388CrossRefPubMed
26.
Zurück zum Zitat Mantzoros C, Petridou E, Dessypris N, Chavelas C, Dalamaga M, Alexe DM et al (2004) Adiponectin and breast cancer risk. J Clin Endocrinol Metab 89(3):1102–1107CrossRefPubMed Mantzoros C, Petridou E, Dessypris N, Chavelas C, Dalamaga M, Alexe DM et al (2004) Adiponectin and breast cancer risk. J Clin Endocrinol Metab 89(3):1102–1107CrossRefPubMed
27.
Zurück zum Zitat Falk RT, Brinton LA, Madigan MP, Potischman N, Sturgeon SR, Malone KE et al (2006) Interrelationships between serum leptin, IGF-1, IGFBP3, C-peptide and prolactin and breast cancer risk in young women. Breast Cancer Res Treat 98(2):157–165CrossRefPubMed Falk RT, Brinton LA, Madigan MP, Potischman N, Sturgeon SR, Malone KE et al (2006) Interrelationships between serum leptin, IGF-1, IGFBP3, C-peptide and prolactin and breast cancer risk in young women. Breast Cancer Res Treat 98(2):157–165CrossRefPubMed
28.
Zurück zum Zitat Brannian JD, Hansen KA (2002) Leptin and ovarian folliculogenesis: implications for ovulation induction and ART outcomes. Semin Reprod Med. 20(2):103–112CrossRefPubMed Brannian JD, Hansen KA (2002) Leptin and ovarian folliculogenesis: implications for ovulation induction and ART outcomes. Semin Reprod Med. 20(2):103–112CrossRefPubMed
29.
Zurück zum Zitat Caprio M, Fabbrini E, Isidori AM, Aversa A, Fabbri A (2001) Leptin in reproduction. Trends Endocrinol Metab 12(2):65–72CrossRefPubMed Caprio M, Fabbrini E, Isidori AM, Aversa A, Fabbri A (2001) Leptin in reproduction. Trends Endocrinol Metab 12(2):65–72CrossRefPubMed
30.
Zurück zum Zitat Nalabolu MR, Palasamudram K, Jamil K (2014) Adiponectin and leptin molecular actions and clinical significance in breast cancer. Int J Hematol Oncol Stem Cell Res. 8(1):31–40PubMedPubMedCentral Nalabolu MR, Palasamudram K, Jamil K (2014) Adiponectin and leptin molecular actions and clinical significance in breast cancer. Int J Hematol Oncol Stem Cell Res. 8(1):31–40PubMedPubMedCentral
31.
Zurück zum Zitat Maskarinec G, Steude JS, Franke AA, Cooney RV (2009) Inflammatory markers in a 2-year soy intervention among premenopausal women. J Inflamm (Lond) 6:9CrossRef Maskarinec G, Steude JS, Franke AA, Cooney RV (2009) Inflammatory markers in a 2-year soy intervention among premenopausal women. J Inflamm (Lond) 6:9CrossRef
32.
Zurück zum Zitat Chia VM, Newcomb PA, White E, Zheng Y, Potter JD, Lampe JW (2008) Reproducibility of serum leptin, insulin-like growth factor-I, and insulin-like growth factor-binding protein-3 measurements. Horm Res 69(5):295–300CrossRefPubMed Chia VM, Newcomb PA, White E, Zheng Y, Potter JD, Lampe JW (2008) Reproducibility of serum leptin, insulin-like growth factor-I, and insulin-like growth factor-binding protein-3 measurements. Horm Res 69(5):295–300CrossRefPubMed
Metadaten
Titel
Circulating leptin and adiponectin, and breast density in premenopausal Mexican women: the Mexican Teachers’ Cohort
verfasst von
L. Dossus
S. Rinaldi
C. Biessy
M. Hernandez
M. Lajous
A. Monge
E. Ortiz-Panozo
E. Yunes
R. Lopez-Ridaura
G. Torres-Mejía
I. Romieu
Publikationsdatum
04.07.2017
Verlag
Springer International Publishing
Erschienen in
Cancer Causes & Control / Ausgabe 9/2017
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-017-0917-8

Weitere Artikel der Ausgabe 9/2017

Cancer Causes & Control 9/2017 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.